Showing results (101-110 of 244) with videos related to

Sort By:
Pageof 25
The Journal of Investigative Dermatology|May 1, 1990
Production of rabbit antibodies against carboxy-terminal epitopes encoded by bullous pemphigoid cDNAT Tanaka, N J Korman, H Shimizu, et al.
Archives of Dermatology|June 19, 2001
Significant absorption of topical tacrolimus in 3 patients with Netherton syndromeA Allen, E Siegfried, R Silverman, et al.
Research and Reports in Urology|May 8, 2023
A Diagnostic Test Combining Molecular Testing with Phenotypic Pooled Antibiotic Susceptibility Improved the Clinical Outcomes of Patients with Non-E. coli or Polymicrobial Complicated Urinary Tract InfectionsHoward J Korman, David Baunoch, Natalie Luke, et al.
Infection and Drug Resistance|May 16, 2023
Multiplex Polymerase Chain Reaction/Pooled Antibiotic Susceptibility Testing Was Not Associated with Increased Antibiotic Resistance in Management of Complicated Urinary Tract InfectionsHoward J Korman, Mohit Mathur, Natalie Luke, et al.
Dermatology and Therapy|May 14, 2025
Patient Experiences of Bullous Pemphigoid: Symptoms and Health-Related Quality of Life ImpactsCalvin N Ho, Lila Bahadori, Marc Yale, et al.
Molecular and Cellular Biology|November 1, 1987
Expression of HLA-DR antigen in human class II mutant B-cell lines by double infection with retrovirus vectorsZ Yang, A J Korman, J Cooper, et al.
Arthritis and Rheumatism|July 1, 1994
Hypocomplementemic urticarial vasculitis syndrome in identical twinsJ J Wisnieski, S N Emancipator, N J Korman, et al.
Journal of the American Academy of Dermatology|October 1, 1992
Paraneoplastic pemphigus: a report of three cases including one long-term survivorC Camisa, T N Helm, Y C Liu, et al.
Inorganic Chemistry|March 9, 2022
Utilization of a Mixed-Ligand Strategy to Tune the Properties of Cuboctahedral Porous Coordination CagesAlexandra M Antonio, Kyle J Korman, Meaghan M Deegan, et al.
The Journal of Dermatological Treatment|August 20, 2016
Assessing the overall benefit of a medication: cumulative benefit of secukinumab over time in patients with moderate-to-severe plaque psoriasisApril W Armstrong, Steven R Feldman, Neil J Korman, et al.
Pageof 25